MonTa Biosciences ApS
Private limited companyCVR 36697016Kongens LyngbyActive
MonTa Biosciences ApS is a private limited company, based in Kongens Lyngby, active in research and experimental development on natural sciences and engineering, founded in 2015. Equity was negative at the end of 2025 (−DKK 10.3m). The company made a loss in both 2024 and 2025, most recently DKK 4.8m. 8 people are registered in the company's management and ownership.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 22% (2024 → 2025), to DKK 1.8m.
- The loss grew: from DKK 3.9m to DKK 4.8m (2024 → 2025).
Management and owners, last 24 months
- New in management: Søren Tulstrup (board member, 30/06/2025).
- Stepped down: Peter Birk Rasmussen (board member, 23/06/2025).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | −13,310 | 2,130 | 1,757 | 2,025 | 1,480 | 1,811 | +22.4% |
| Operating profit (EBIT) | −15,655 | −1,318 | −1,325 | −1,749 | −2,053 | −1,986 | +3.3% |
| Profit before tax | −16,447 | −2,613 | −3,239 | −4,580 | −5,400 | −6,539 | −21.1% |
| Net profit | −13,293 | 1,406 | −1,439 | −3,279 | −3,921 | −4,777 | −21.8% |
| Total assets | 20,395 | 35,016 | 49,154 | 73,387 | 83,384 | 103,652 | +24.3% |
| Equity | 1,704 | 3,111 | 1,672 | −1,607 | −5,528 | −10,305 | −86.4% |
| Liabilities | 16,598 | 30,463 | 44,216 | 71,152 | 85,545 | 110,156 | +28.8% |
| Cash and cash equivalents | 5,293 | 1,793 | 4,010 | 13,172 | 6,878 | 8,052 | +17.1% |
| Average number of employees | 4 | 3 | 3 | 4 | 3 | 3 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 10.3m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 4 years in a row
Net result has been negative in 2022–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 19/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 13/05/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 15/05/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 14/04/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 19/04/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 12/04/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 33,023of 69,742 Better than 53% | No. 69,598of 69,964 Better than 1% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 92of 323 Better than 72% | No. 311of 329 Better than 5% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 17,845of 33,588 Better than 47% | No. 33,361of 33,687 Better than 1% |
| All companies of type ApS66,508 companies in the comparison | No. 31,962of 66,379 Better than 52% | No. 66,134of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- MonTa Biosciences ApSDKK 1.8m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- MonTa Biosciences ApS−DKK 4.8m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- MonTa Biosciences ApS−DKK 10.3m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- MonTa Biosciences ApS4
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Jonas Rosager Henriksen5%
- Tla-holding 2010 ApS10%
- Jensen Bioconsult ApS15%
- Consolidated Biosciences ApS50%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Simon Skjøde Jensen | CEO | 26/03/2015 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Esper Boel | Board member | 22/02/2017 |
| Sven Madsen | Board member | 22/01/2019 |
| Lone Schøtt Kunøe | Chair of the board | 28/03/2023 |
| Søren Tulstrup | Board member | 30/06/2025 |
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Founders
- Jonas Rosager Henriksen, Ladan Roursgaard, Tla-holding 2010 ApS, Jensen Bioconsult ApS
Former management (5)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Thomas Lars Andresen | Director | 26/03/2015 | 01/07/2023 |
| Thomas Lars Andresen | Board member | 22/02/2017 | 22/01/2019 |
| Peter Birk Rasmussen | Chair of the board | 22/02/2017 | 27/03/2023 |
| Lone Schøtt Kunøe | Board member | 22/01/2019 | 27/03/2023 |
| Peter Birk Rasmussen | Board member | 28/03/2023 | 23/06/2025 |
Signing rule: Selskabet tegnes af Selskabets administrerende direktør og bestyrelsesformanden i forening eller af den samlede bestyrelse.
Address and production units
1 active production unitsDiplomvej 377
2800 Kongens Lyngby
Lyngby-Taarbæk Municipality · Postcode 2800
Other companies at the address (1)
- ABH Optics ApSOptician activities
| Production unit | Address | Employees | P number |
|---|---|---|---|
| MonTa Biosciences ApS | Diplomvej 377, 1, 2800 Kongens Lyngby | 4 | 1020270930 |
Purpose
Selskabets formål er at drive forretning med udvikling og handel af målrettet lipidbaseret leveringsteknologi samt behandlinger af kræft, herunder projektet vedrørende udvikling af en stærk datapakke for TLR7 agonist 1V270 lipid formulering og dens immunoterapeutiske aktivitet til behandling af kræft med henblik på at opnå væsentlig kommerciel værdiskabelse og andre relaterede aktiviteter.
The purpose is quoted from the register in Danish.
Changes year by year
76 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20254 changesmanagement 2 · accounts 1 · industry 1
- ManagementSøren Tulstrup appointed board member
- ManagementPeter Birk Rasmussen stepped down as board member
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20237 changesmanagement 5 · accounts 1 · address 1
- ManagementThomas Lars Andresen stepped down as director
- AccountsAnnual report for 2022 published
- AddressMoved to Diplomvej 377, 1, 2800 Kongens Lyngby
- ManagementLone Schøtt Kunøe appointed chair of the board
- ManagementPeter Birk Rasmussen appointed board member
- ManagementLone Schøtt Kunøe stepped down as board member
- ManagementPeter Birk Rasmussen stepped down as chair of the board
20228 changesownership 7 · accounts 1
- OwnershipTLA-HOLDING 2010 ApS registered as owner (10%)
- OwnershipConsolidated Biosciences ApS registered as owner (50%)
- OwnershipJENSEN BIOCONSULT ApS registered as owner (15%)
- OwnershipUddannelses- og Forskningsstyrelsen is no longer registered as owner
- OwnershipJENSEN BIOCONSULT ApS is no longer registered as owner
- OwnershipTLA-HOLDING 2010 ApS is no longer registered as owner
- OwnershipConsolidated Biosciences ApS is no longer registered as owner
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
201921 changescapital 2 · ownership 14 · address 2 · management 3
- CapitalShare capital changed from 2,616,897 DKK to 2,629,981 DKK
- OwnershipJENSEN BIOCONSULT ApS registered as owner (15%)
- OwnershipTLA-HOLDING 2010 ApS registered as owner (10%)
- OwnershipTLA-HOLDING 2010 ApS is no longer registered as owner
- OwnershipJENSEN BIOCONSULT ApS is no longer registered as owner
- AddressMoved to Diplomvej 377, 1, 2800 Kongens Lyngby
- AddressMoved to Diplomvej 377, 1, 2800 Kongens Lyngby
- CapitalShare capital changed from 1,322,827 DKK to 2,616,897 DKK
- ManagementLone Schøtt Kunøe appointed board member
- ManagementSven Madsen appointed board member
- ManagementThomas Lars Andresen stepped down as board member
- OwnershipTLA-HOLDING 2010 ApS registered as owner (10%)
- OwnershipConsolidated Biosciences ApS registered as owner (33.33%)
- OwnershipJENSEN BIOCONSULT ApS registered as owner (15%)
- OwnershipUddannelses- og Forskningsstyrelsen registered as owner (10%)
- OwnershipJonas Rosager Henriksen registered as owner (5%)
- OwnershipAnders Elias Hansen is no longer registered as owner
- OwnershipUddannelses- og Forskningsstyrelsen is no longer registered as owner
- OwnershipJENSEN BIOCONSULT ApS is no longer registered as owner
- OwnershipTLA-HOLDING 2010 ApS is no longer registered as owner
- OwnershipJonas Rosager Henriksen is no longer registered as owner
20176 changescapital 1 · management 3 · ownership 2
- CapitalShare capital changed from 84,000 DKK to 1,322,827 DKK
- ManagementThomas Lars Andresen appointed board member
- ManagementEsper Boel appointed board member
- ManagementPeter Birk Rasmussen appointed chair of the board
- OwnershipUddannelses- og Forskningsstyrelsen registered as owner (20%)
- OwnershipLadan Roursgaard is no longer registered as owner
201619 changesownership 17 · name 1 · capital 1
- OwnershipJENSEN BIOCONSULT ApS registered as owner (25%)
- OwnershipTLA-HOLDING 2010 ApS registered as owner (20%)
- OwnershipJENSEN BIOCONSULT ApS is no longer registered as owner
- OwnershipTLA-HOLDING 2010 ApS is no longer registered as owner
- NameName changed from MonTa Biosciences IVS to MonTa Biosciences ApS
- CapitalShare capital changed from 100 DKK to 84,000 DKK
- OwnershipAnders Elias Hansen registered as owner (5%)
- OwnershipJENSEN BIOCONSULT ApS registered as owner (33.33%)
- OwnershipTLA-HOLDING 2010 ApS registered as owner (25%)
- OwnershipLadan Roursgaard registered as owner (5%)
- OwnershipJonas Rosager Henriksen registered as owner (10%)
- OwnershipJonas Rosager Henriksen is no longer registered as owner
- OwnershipAnders Elias Hansen is no longer registered as owner
- OwnershipLadan Roursgaard is no longer registered as owner
- OwnershipJENSEN BIOCONSULT ApS is no longer registered as owner
- OwnershipTLA-HOLDING 2010 ApS is no longer registered as owner
- OwnershipJonas Rosager Henriksen registered as owner (10%)
- OwnershipAnders Elias Hansen registered as owner (10%)
- OwnershipJonas Rosager Henriksen is no longer registered as owner
20158 changesstatus 1 · management 2 · founded 1 · ownership 4
- StatusStatus changed to active
- ManagementSimon Skjøde Jensen appointed ceo
- ManagementThomas Lars Andresen appointed director
- FoundedRegistered as MonTa Biosciences IVS
- OwnershipLadan Roursgaard registered as owner (5%)
- OwnershipJENSEN BIOCONSULT ApS registered as owner (33.33%)
- OwnershipTLA-HOLDING 2010 ApS registered as owner (25%)
- OwnershipJonas Rosager Henriksen registered as owner (15%)
Related companies
Same industry in Lyngby-Taarbæk
- Thales Aerospace Communications Lyngby ApS52 employees
- Immudex ApS35 employees
- Capres A/S34 employees
- Novo Nordisk Foundation Cellerator A/S33 employees
- Mdsi ApS33 employees
- Bifrost Communications ApS9 employees
Same people in management
- Atea A/Svia Sven Madsen
- Columbus A/Svia Sven Madsen
- CTS Denmark A/Svia Lone Schøtt Kunøe
- X-yachts A/Svia Lone Schøtt Kunøe
- Dansk Emballage A/Svia Sven Madsen
- Compass Human Resources Group A/Svia Sven Madsen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.